Related Experiment Video
Updated: Jul 12, 2026

Effects of Mindfulness Training Combined with Tai Chi in Patients with Diabetic Peripheral Neuropathy
Published on: July 14, 2023
Safety profile of treatment in diabetic peripheral neuropathic pain
Jessica Robinson-Papp1, David M Simpson
1Mount Sinai School of Medicine, New York, New York, USA. Jessica.robinson-papp@mssm.edu
Abstract:
New treatment options for diabetic peripheral neuropathic pain (DPNP) have recently been developed, including two Food and Drug Administration (FDA) approved agents, duloxetine and pregabalin. As clinicians face a broader spectrum of efficacious treatments, side-effect profiles play an increasingly important role in the development of a pain management regimen. In this article we review the safety profile of agents commonly used in the treatment of DPNP.
Related Concept Videos
Diabetic Neuropathy
Peripheral Artery Disease V: Postoperative Nursing Management
Peripheral Artery Disease IV: Nursing Management
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Diabetic Foot Ulcer
Local Anesthetics: Differential Sensitivity of Nerve Fibers